DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles

Nasolabial Fold Wrinkles Clinical Trial

Official title:
A Randomized Study of the Safety and Effectiveness of DL6049 (Injectable Poly-L-lactic Acid) Versus CosmoPlast Collagen Implant in the Treatment of Nasolabial Fold Wrinkles

Status Completed

Clinical Trial Summary

This study is being undertaken to:

- evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial fold wrinkles at 13 months following the last application of study treatment.

- Document the types and incidence of adverse events reported with DL6049 (injectable poly-L-lactic acid)compared with CosmoPlast™ Collagen Implant. Long term adverse events will be assessed for an additional 12 months following discharge from the main study in subjects treated with DL6049.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Nasolabial Fold Wrinkles

Clinical Trial Details

NCT number	NCT00444210
Study type	Interventional
Source	Bausch Health Americas, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	June 2004
Completion date	April 2006

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05162326` - BC-101 in Treatment of Nasolabial Fold Wrinkles	Phase 1
Completed	`NCT00444353` - DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up	Phase 3
Recruiting	`NCT06013332` - Polymeric Microspheres vs Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds	N/A